RefleXion Acquires Global Rights to Radiopharmaceutical Molecule from 3B Pharmaceuticals to Treat High Unmet Need Cancers

New molecule to enable RefleXion’s SCINTIX therapy to treat most solid tumors

Related Keywords

Thorsten Melcher ,Ulrich Reineke ,Reflexion Medical Inc ,Pb Pharmaceuticals ,Stanford Medicine Cancer Center ,Reflexion Medical ,Global Exclusive Licensing Agreement ,Novartis Innovative Therapies ,Stanford Medicine Cancer ,